Heather Orom1, Christian J Nelson2, Willie Underwood3, D Lynn Homish1, Deepak A Kapoor4,5. 1. Department of Community Health and Health Behavior, University at Buffalo, Buffalo, NY, USA. 2. Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. Department of Urology, Roswell Park Cancer Institute, Buffalo, NY, USA. 4. Integrated Medical Professionals, PLLC, Melville, NY, USA. 5. Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract
OBJECTIVE: Early identification and intervention have been recommended for newly diagnosed prostate cancer patients who experience significant emotional distress; however, there is little empirical basis for designing or selecting interventions for these men. We sought to identify factors that are associated with distress in these men as a basis for identifying suitable intervention strategies. METHODS: Using cross-sectional data and validated scales, we investigated the extent to which clinical, demographic, belief, and personality characteristics are associated with emotional distress assessed with the Distress Thermometer in 1425 men newly diagnosed with clinically localized prostate cancer (pretreatment). RESULTS: Beliefs potentially amenable to psychoeducational interventions [low self-efficacy for decision-making (B =-0.11, p = 0.02), low confidence in cancer control (B =-0.03, p < 0.001), and masculine identity threat (B =-0.26, p = 0.001)] were associated with higher emotional distress, as well as personality factors [low optimism (B =-0.04, p = 0.052) and low resilience (B =-0.83, p < 0.001)]. CONCLUSIONS: Findings provide a framework for the development of interventions for prostate cancer patients with elevated emotional distress. These may include improving provider communication about prostate cancer prognosis for those with low confidence in cancer control, providing decision-making support to increase decision-making self-efficacy, or referral to brief cognitive behavioral interventions to help patients reframe masculine identity threat or for those with low optimism or resilience reframe and adjust to the health threat.
OBJECTIVE: Early identification and intervention have been recommended for newly diagnosed prostate cancerpatients who experience significant emotional distress; however, there is little empirical basis for designing or selecting interventions for these men. We sought to identify factors that are associated with distress in these men as a basis for identifying suitable intervention strategies. METHODS: Using cross-sectional data and validated scales, we investigated the extent to which clinical, demographic, belief, and personality characteristics are associated with emotional distress assessed with the Distress Thermometer in 1425 men newly diagnosed with clinically localized prostate cancer (pretreatment). RESULTS: Beliefs potentially amenable to psychoeducational interventions [low self-efficacy for decision-making (B =-0.11, p = 0.02), low confidence in cancer control (B =-0.03, p < 0.001), and masculine identity threat (B =-0.26, p = 0.001)] were associated with higher emotional distress, as well as personality factors [low optimism (B =-0.04, p = 0.052) and low resilience (B =-0.83, p < 0.001)]. CONCLUSIONS: Findings provide a framework for the development of interventions for prostate cancerpatients with elevated emotional distress. These may include improving provider communication about prostate cancer prognosis for those with low confidence in cancer control, providing decision-making support to increase decision-making self-efficacy, or referral to brief cognitive behavioral interventions to help patients reframe masculine identity threat or for those with low optimism or resilience reframe and adjust to the health threat.
Authors: Mieke J Aarts; Floortje Mols; Melissa S Y Thong; Marieke W Louwman; Jan Willem W Coebergh; Lonneke V van de Poll-Franse Journal: Urology Date: 2010-11 Impact factor: 2.649
Authors: Anna Bill-Axelson; Hans Garmo; Lars Holmberg; Jan-Erik Johansson; Hans-Olov Adami; Gunnar Steineck; Eva Johansson; Jennifer R Rider Journal: Eur Urol Date: 2013-02-26 Impact factor: 20.096
Authors: Rebecca Cowens-Alvarado; Katherine Sharpe; Mandi Pratt-Chapman; Anne Willis; Ted Gansler; Patricia A Ganz; Stephen B Edge; Mary S McCabe; Kevin Stein Journal: CA Cancer J Clin Date: 2013-03-19 Impact factor: 508.702
Authors: Suzanne K Chambers; Leah Zajdlewicz; Danny R Youlden; Jimmie C Holland; Jeff Dunn Journal: Psychooncology Date: 2013-09-12 Impact factor: 3.894